SCHEDULE 13G/A
Statement of Beneficial Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001388325-26-000053
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Novo Holdings A/S | 3,000,000 | 5.4% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…